News & Perspective

Apr 09, 2003

Apr 09, 2003

WHO official says SARS has peaked outside China

(CIDRAP News) – A World Health Organization (WHO) official today said the peak of the epidemic of severe acute respiratory syndrome (SARS) has passed in places other than China and Hong Kong, despite the continuing increase in cases.

Dec 24, 2003

Dec 24, 2003

USDA says first US BSE case poses little risk

(CIDRAP News) – Federal officials took pains to assure the public today that the risk of contamination in the US beef supply is very low following yesterday's announcement that the nation's first apparent case of bovine spongiform encephalopathy (BSE), or mad cow disease, had turned up in Washington state.

Apr 08, 2005

Apr 08, 2005

Marburg outbreak jumps to 200 cases

(CIDRAP News) – The toll in Angola's epidemic of Marburg hemorrhagic fever has continued to climb sharply, reaching 174 deaths out of 200 cases, according to the latest reports.

Oct 27, 2008

Oct 27, 2008

Drug-resistant flu viruses cause growing concern

– WASHINGTON, DC (CIDRAP News) – Health officials worldwide are becoming increasingly concerned about influenza viruses' resistance to antiviral drugs, which can shut down a flu infection or mitigate symptoms. Flu antivirals are vital for reducing severe illness and death in average flu seasons and could be essential bulwarks against an influenza pandemic if one began.

Oct 29, 2008

Oct 29, 2008

Experts stress vigilance over emerging, unpredictable diseases

See related article posted today: "US urged to launch major campaign against emerging diseases"

– WASHINGTON, DC (CIDRAP News) – Health authorities must remain alert to new and renascent disease threats, experts warned this week at an international medical meeting.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Dec 19, 2008

Dec 19, 2008

With H1N1 resistance, CDC changes advice on flu drugs

(CIDRAP News) – Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»